Canada Markets closed

MedMen Enterprises Inc. (MMEN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2000-0.0100 (-4.76%)
At close: 03:59PM EST
Full screen
Previous Close0.2100
Open0.2100
Bid0.2000 x 0
Ask0.2050 x 0
Day's Range0.2000 - 0.2150
52 Week Range0.1900 - 1.8300
Volume733,670
Avg. Volume727,530
Market Cap239.55M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-0.3070
Earnings DateFeb. 14, 2022 - Feb. 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.34
  • Business Wire

    MedMen’s Tracy McCourt Appointed President of West Hollywood Cannabis Organization

    LOS ANGELES, January 13, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQB: MMNFF), a leading cannabis retailer with operations across the nation, today announced the appointment of Tracy McCourt, Chief Revenue Officer, to President of Emerald Village West Hollywood. Established in 2021, Emerald Village West Hollywood is the official marketing organization for licensed cannabis businesses in West Hollywood.

  • Business Wire

    MedMen Expands Brand Portfolio With Boutique Strains From Fog City Farms

    LOS ANGELES, January 11, 2022--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced it will carry new products from Fog City Farms, a Santa Cruz-based cannabis cultivation company specializing in sustainable growing and business practices, with an emphasis on boutique strains. Beginning January 23, unique small-batch strains cultivated in Fog City Farms’ state-of-the-art vertical growing pla

  • GlobeNewswire

    Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

    New Parent Company Name, TILRAY BRANDS, Reflects Growing Portfolio of Leading, Global CPG BrandsNet Revenue Increased ~20% to $155 Million from the Prior Year Quarter Net Income Improved $95 Million to $6 Million from the Prior Year QuarterAdjusted EBITDA of $13.8 Million, 11th Consecutive Quarter of Positive Adjusted EBITDAAchieved $70 Million in Cost Synergies To Date; On-Track to Exceed Original Plan of $80 Million Ahead of Schedule and to Generate Additional $20 Million of Synergies in Fisca